Sanofi’s Tzield Gains FDA Approval in Stage 3 Type 1 Diabetes
PARIS, France, June 13, 2026 Sanofi has achieved a major breakthrough in diabetes care after the U.S. Food and...
pediatric diabetes
Advertisement
MannKind Gains FDA Approval for Afrezza in Pediatric Diabetes
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 29, 2026 MannKind Corporation announced that the U.S. Food and Drug Administration...
Novo Nordisk Oral Semaglutide Shows Pediatric Breakthrough
Bagsværd, Denmark – April 23, 2026 In a major advancement for pediatric diabetes care, Novo Nordisk announced positive Phase...
Sanofi Secures FDA Approval for Tzield in Young T1D
Paris, France – April 22, 2026 In a landmark advancement for pediatric endocrinology, Sanofi has secured U.S. FDA approval...
Advertisement
